Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib

M. Mian, N. Pescosta, S. Badiali, P.C. Cappelletto, L. Marcheselli, S. Luminari, F. Patriarca, R. Zambello, A. Pascarella, G. Tagariello, A. Marabese, P. Mondello, A. Billio, S. Cortelazzo

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)944-947
Number of pages4
JournalBritish Journal of Haematology
Volume185
Issue number5
DOIs
Publication statusPublished - 2019

Cite this

Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib. / Mian, M.; Pescosta, N.; Badiali, S.; Cappelletto, P.C.; Marcheselli, L.; Luminari, S.; Patriarca, F.; Zambello, R.; Pascarella, A.; Tagariello, G.; Marabese, A.; Mondello, P.; Billio, A.; Cortelazzo, S.

In: British Journal of Haematology, Vol. 185, No. 5, 2019, p. 944-947.

Research output: Contribution to journalArticle

Mian, M, Pescosta, N, Badiali, S, Cappelletto, PC, Marcheselli, L, Luminari, S, Patriarca, F, Zambello, R, Pascarella, A, Tagariello, G, Marabese, A, Mondello, P, Billio, A & Cortelazzo, S 2019, 'Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib', British Journal of Haematology, vol. 185, no. 5, pp. 944-947. https://doi.org/10.1111/bjh.15645
Mian, M. ; Pescosta, N. ; Badiali, S. ; Cappelletto, P.C. ; Marcheselli, L. ; Luminari, S. ; Patriarca, F. ; Zambello, R. ; Pascarella, A. ; Tagariello, G. ; Marabese, A. ; Mondello, P. ; Billio, A. ; Cortelazzo, S. / Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib. In: British Journal of Haematology. 2019 ; Vol. 185, No. 5. pp. 944-947.
@article{bfd1a0d8baaf47269f5a5a5b239645ef,
title = "Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib",
author = "M. Mian and N. Pescosta and S. Badiali and P.C. Cappelletto and L. Marcheselli and S. Luminari and F. Patriarca and R. Zambello and A. Pascarella and G. Tagariello and A. Marabese and P. Mondello and A. Billio and S. Cortelazzo",
note = "Export Date: 3 July 2019 CODEN: BJHEA Correspondence Address: Mian, M.; Department of Haematology & CBMT, Hospital of BolzanoItaly; email: m.mian@med-sci.eu",
year = "2019",
doi = "10.1111/bjh.15645",
language = "English",
volume = "185",
pages = "944--947",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "5",

}

TY - JOUR

T1 - Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib

AU - Mian, M.

AU - Pescosta, N.

AU - Badiali, S.

AU - Cappelletto, P.C.

AU - Marcheselli, L.

AU - Luminari, S.

AU - Patriarca, F.

AU - Zambello, R.

AU - Pascarella, A.

AU - Tagariello, G.

AU - Marabese, A.

AU - Mondello, P.

AU - Billio, A.

AU - Cortelazzo, S.

N1 - Export Date: 3 July 2019 CODEN: BJHEA Correspondence Address: Mian, M.; Department of Haematology & CBMT, Hospital of BolzanoItaly; email: m.mian@med-sci.eu

PY - 2019

Y1 - 2019

U2 - 10.1111/bjh.15645

DO - 10.1111/bjh.15645

M3 - Article

VL - 185

SP - 944

EP - 947

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 5

ER -